[1] Sen S,Zhou H,White RA.A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amphfied and overexpressed in human breast cancer cellines[J].Oncogene,1997,14(18):2195-2200.[2] Tatsuka M,Sato S,Kanda A,et al.Oncogenic role of nuclear accumulated Aurora-A[J].Mol Carcinog,2009,48(9):810-820.[3] Yeh CN,Yen CC,Chen YY,et al.Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors[J].Oncotarget,2014,5(12):4071-4086.[4] Lu Y,Liu Y,Jiang J,et al.Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells[J].Oncol Rep,2014,32(1):243-249.[5] Weier HU,Mao JH.Meta-analysis of Aurora kinase A (AURKA) expression data reveals a significant correlation between increased AURKA expression and distant metastases in human ER-positive breast cancers[J].J Data Mining Genomics Proteomics,2013,4(1):127-132.[6] Qu Y,Huang X,Li Z,et al.miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment[J].Am J Pathol,2014,184(5):1541-1549.[7] Kwon YW,Kim IJ,Wu D,et al.Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development[J].Mol Cancer Res,2012,10(6):834-844.[8] Long M,Yin G,Liu L,et al.Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells[J].Cancer Gene Ther,2012,19(4):271-281.[9] Silva A,Wang J,Lomahan S,et al.Aurora kinase A is a possible target of OSU 03012 to destabilize MYC family proteins[J].Oncol Rep,2014,32(3):901-905.[10] Petersen W,Liu J,Yuan L,et al.Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283[J].Cancer Lett,2014,354(1):68-76.[11] Braun A,Dang K,Buslig F,et al.Rac1 and Aurora A regulate MCAK to polarize microtubule growth in migrating endothelial cells[J].J Cell Biol,2014,206(1):97-112.[12] Sumi K,Tago K,Kasahara T,et al.Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cells[J].FEBS Lett,2011,585(12):1884-1890.[13] Santo L,Hideshima T,Cirstea D,et al.Antimyeloma activity of a multitargeted kinase inhibitor,AT9283,via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide[J].Clin Cancer Res,2011,17(10):3259-3271.[14] Takitoh T,Kumamoto K,Wang CC,et al.Activation of Aurora-A is essential for neuronal migration via modulation of microtubule organization[J].J Neurosci,2012,32(32):11050-11066.[15] Do TV,Xiao F,Bickel LE,et al.Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion[J].Oncogene,2014,33(5):539-549.[16] Gustafson LM,Gleich LL,Fukasawa K,et al.Centrosome hyperamplification in head and neck squamous cell carcinoma: a potential phenotypic marker of tumor aggressiveness[J].Laryngoscope,2000,110(11):1798-1801.[17] Zhu J,Abbruzzese JL,Izzo J,et al.AURKA amplification,chromosome instability,and centrosome abnormality in human pancreatic carcinoma cells[J].Cancer Genet Cytogenet,2005,159(1):10-17.[18] Leontovich AA,Salisbury JL,Veroux M,et al.Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells[J].Oncol Rep,2013,29(5):1785-1788. |